Targeted Medical Pharma to Present at Sachs Associated 14th Annual Biotech in Europe Forum for Global Partnering and Investment
2014年9月16日 - 11:00PM
ビジネスワイヤ(英語)
Targeted Medical Pharma (OTCQB:TRGM), today announced that
William Shell, M.D., Chairman, CSO and CEO is scheduled to present
the latest company information regarding the advances in
therapeutic nutrition and medical foods technology, at the
14th Annual Biotech in Europe Forum at the Congress Center in
Basel, Switzerland. The presentation is scheduled for September
30th, 2014 at 11:45 am in the Lima Room. Dr. Shell will also
be a panelist in the discussion regarding advancements in
Neuroscience at 3:30 pm.
Additional information about the conference may be found
at www.sachsforum.com. Attendees who wish to meet with
management one on one may contact our Investor Relations
department: investors@tmedpharma.com
About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. (OTCQB: TRGM) is a publicly
traded, Los Angeles-based biotechnology company that is committed
to drug discovery and development. The company currently develops
and distributes amino acid based medical foods, a rapidly growing
sector of medication technology, for the treatment of chronic
disease, including pain syndromes, peripheral neuropathy,
hypertension, obesity, sleep and cognitive disorders using the
patented system of Targeted Cellular Technology.
The company also develops a line of dietary supplements designed
to support health and wellness. TMP currently manufactures 10
proprietary amino acid based medical foods, and recently launched
its first dietary supplement, Clearwayz™. The products are sold
directly to physicians and pharmacies in the U.S. The Company is
also developing nutrient-based systems for oral stimulation of
progenitor stem cells that differentiate into neurons, red blood
cells, pituitary hormones including IGF-I.
Follow the Company on twitter @tmedpharma.
Investor
Contact:Targeted Medical PharmaWilliam
Horne310-474-9809whorne@tmedpharma.com
Targeted Medical Pharma (CE) (USOTC:TRGM)
過去 株価チャート
から 11 2024 まで 12 2024
Targeted Medical Pharma (CE) (USOTC:TRGM)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Targeted Medical Pharma Inc (CE) (その他OTC): 0 recent articles
その他のTargeted Medical Pharma, Inc. (QB)ニュース記事